• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌手术切除率对生存率的影响:全国性研究

Impact of surgical resection rate on survival in gastric cancer: nationwide study.

作者信息

Kung C-H, Jestin Hannan C, Linder G, Johansson J, Nilsson M, Hedberg J, Lindblad M

机构信息

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Department of Surgery, Skellefteå County Hospital, Skellefteå, Sweden.

出版信息

BJS Open. 2021 Mar 5;5(2). doi: 10.1093/bjsopen/zraa017.

DOI:10.1093/bjsopen/zraa017
PMID:33688944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7944854/
Abstract

BACKGROUND

There are marked geographical variations in the proportion of patients undergoing resection for gastric cancer. This study investigated the impact of resection rate on survival.

METHODS

All patients with potentially curable gastric cancer between 2006 and 2017 were identified from the Swedish National Register of Oesophageal and Gastric Cancer. The annual resection rate was calculated for each county per year. Resection rates in all counties for all years were grouped into tertiles and classified as low, intermediate or high. Survival was analysed using the Cox proportional hazards model.

RESULTS

A total of 3465 patients were diagnosed with potentially curable gastric cancer, and 1934 (55.8 per cent) were resected. Resection rates in the low (1261 patients), intermediate (1141) and high (1063) tertiles were 0-50.0, 50.1-62.5 and 62.6-100 per cent respectively. The multivariable Cox analysis revealed better survival for patients diagnosed in counties during years with an intermediate versus low resection rate (hazard ratio (HR) 0.81, 95 per cent c.i. 0.74 to 0.90; P < 0.001) and high versus low resection rate (HR 0.80, 0.73 to 0.88; P < 0.001).

CONCLUSION

This national register study showed large regional variation in resection rates for gastric cancer. A higher resection rate appeared to be beneficial with regard to overall survival for the entire population.

摘要

背景

接受胃癌切除术的患者比例存在显著的地域差异。本研究调查了切除率对生存的影响。

方法

从瑞典国家食管癌和胃癌登记处识别出2006年至2017年间所有可能治愈的胃癌患者。计算每年每个县的年切除率。将所有年份所有县的切除率分为三分位数,并分为低、中、高三类。使用Cox比例风险模型分析生存情况。

结果

共有3465例患者被诊断为可能治愈的胃癌,其中1934例(55.8%)接受了手术切除。低三分位数组(1261例患者)、中三分位数组(1141例)和高三分位数组(1063例)的切除率分别为0 - 50.0%、50.1 - 62.5%和62.6 - 100%。多变量Cox分析显示,与低切除率年份相比,中切除率年份诊断的患者生存情况更好(风险比(HR)0.81,95%置信区间0.74至0.90;P < 0.001),高切除率年份与低切除率年份相比也是如此(HR 0.80,0.73至0.88;P < 0.001)。

结论

这项全国登记研究表明,胃癌切除率存在很大的地区差异。较高的切除率似乎对整个人口的总体生存有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/dc053cce04f7/zraa017f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/9a7c692a36cd/zraa017f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/5488db6f13f5/zraa017f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/dc053cce04f7/zraa017f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/9a7c692a36cd/zraa017f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/5488db6f13f5/zraa017f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e4/7944854/dc053cce04f7/zraa017f3.jpg

相似文献

1
Impact of surgical resection rate on survival in gastric cancer: nationwide study.胃癌手术切除率对生存率的影响:全国性研究
BJS Open. 2021 Mar 5;5(2). doi: 10.1093/bjsopen/zraa017.
2
Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.胃癌组织学类型、位置、分期及手术治疗结果的变化模式。
Br J Surg. 2000 May;87(5):618-26. doi: 10.1046/j.1365-2168.2000.01425.x.
3
Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.癌症患者的癌症治疗和生存的地理差异:食管和胃食管交界处癌症。
Br J Surg. 2020 Oct;107(11):1500-1509. doi: 10.1002/bjs.11671. Epub 2020 Jun 2.
4
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.年龄和合并症对食管和胃癌患者手术切除率和生存率的影响。
Br J Surg. 2012 Dec;99(12):1693-700. doi: 10.1002/bjs.8952.
5
Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.全国性研究:D2 淋巴结清扫术对胃癌手术后生存的影响。
BJS Open. 2020 Jun;4(3):424-431. doi: 10.1002/bjs5.50270. Epub 2020 Mar 4.
6
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.胃癌D1和D2切除术后患者的生存率:MRC随机外科试验的长期结果。外科合作组。
Br J Cancer. 1999 Mar;79(9-10):1522-30. doi: 10.1038/sj.bjc.6690243.
7
Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.接受手术探查但未行切除术的胰腺癌患者的全国性结局。
Br J Surg. 2017 Oct;104(11):1568-1577. doi: 10.1002/bjs.10602. Epub 2017 Aug 22.
8
Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.胃中三分之一腺癌——临床病理特征预后意义的评估
Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.
9
Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.年龄对局部晚期或转移性胃癌患者姑息性手术和化疗使用率的影响。
Br J Surg. 2017 Dec;104(13):1837-1846. doi: 10.1002/bjs.10621. Epub 2017 Aug 9.
10
The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.扩大淋巴结清扫术对胃腺癌患者生存率的影响。
J Am Coll Surg. 1995 Jul;181(1):56-64.

引用本文的文献

1
Impact of surgical resection on the survival in Mexican patients with gastric cancer: A meta-analysis and systematic review.手术切除对墨西哥胃癌患者生存的影响:荟萃分析和系统评价。
Medicine (Baltimore). 2023 Jun 9;102(23):e33915. doi: 10.1097/MD.0000000000033915.
2
Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery.用于预测手术治疗 III 期胃癌患者预后的综合氧化应激评分。
Pathol Oncol Res. 2023 Jun 2;29:1610897. doi: 10.3389/pore.2023.1610897. eCollection 2023.

本文引用的文献

1
Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.全国性研究:D2 淋巴结清扫术对胃癌手术后生存的影响。
BJS Open. 2020 Jun;4(3):424-431. doi: 10.1002/bjs5.50270. Epub 2020 Mar 4.
2
Inter-hospital variation in resection rates of colon cancer in the Netherlands: A nationwide study.荷兰医院间结肠癌切除术率的差异:一项全国性研究。
Eur J Surg Oncol. 2019 Oct;45(10):1882-1886. doi: 10.1016/j.ejso.2019.06.012. Epub 2019 Jun 8.
3
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗(FLOT4):一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.手术和术前化疗后可切除胃癌的化疗与放化疗(CRITICS):一项国际、开放标签、随机 3 期试验。
Lancet Oncol. 2018 May;19(5):616-628. doi: 10.1016/S1470-2045(18)30132-3. Epub 2018 Apr 9.
6
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.欧洲和美国的胰腺癌切除术:一项强调巨大差异的国际大规模研究。
Gut. 2019 Jan;68(1):130-139. doi: 10.1136/gutjnl-2017-314828. Epub 2017 Nov 20.
7
Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden.在瑞典,淋巴结清扫范围对胃癌手术后的术后并发症并无影响。
Chin J Cancer Res. 2017 Aug;29(4):313-322. doi: 10.21147/j.issn.1000-9604.2017.04.04.
8
Validation of data quality in the Swedish National Register for Oesophageal and Gastric Cancer.瑞典食管和胃癌国家登记处数据质量的验证。
Br J Surg. 2016 Sep;103(10):1326-35. doi: 10.1002/bjs.10234. Epub 2016 Jul 28.
9
Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.诊断医院和可切除胃癌手术治疗的可能性。
Br J Surg. 2016 Feb;103(3):233-41. doi: 10.1002/bjs.10054. Epub 2015 Dec 1.
10
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.比较卡培他滨和顺铂辅助化疗与同期放化疗治疗胃癌的 III 期临床试验:胃癌辅助放化疗临床试验的最终报告,包括生存和亚组分析。
J Clin Oncol. 2015 Oct 1;33(28):3130-6. doi: 10.1200/JCO.2014.58.3930. Epub 2015 Jan 5.